Marinus Pharmaceuticals to Present at SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum
Marinus Pharmaceuticals, Inc. is apharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders.
- Marinus Pharmaceuticals, Inc. is apharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders.
- Ganaxolone is a positive allosteric modulator of GABAAreceptors that acts on a well-characterized target in the brain known to have anti-seizure, anti-depressant, and anti-anxiety effects.
- Ganaxolone is being developed in IV and oral dose forms intended to maximize therapeutic reach to adult and pediatric patient populations in both acute and chronic care settings.
- The Company intends to initiate a Phase 3 trial in status epilepticus.